Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
United European Gastroenterology Journal|March 11, 2025
Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care UnitMarika Rudler, Marie de Matharel, Charlotte Bouzbib, et al.Hepatology (Baltimore, Md.)|May 15, 2023
Current challenges and future perspectives in treating patients with NAFLD-related cirrhosisMaxime Mallet, Cristina Alina Silaghi, Philippe Sultanik, et al.Annals of Internal Medicine|June 16, 2010
Brief communication: case reports of ribavirin treatment for chronic hepatitis EVincent Mallet, Elisabeth Nicand, Philippe Sultanik, et al.JHEP Reports : Innovation in Hepatology|February 13, 2026
Animal naming test at discharge is associated with hepatic encephalopathy after elective TIPSMelisande Jorus, Philippe Sultanik, Charlotte Bouzbib, et al.Journal of Intensive Medicine|April 29, 2024
Protein-S-100-beta is increased in patients with decompensated cirrhosis admitted to ICUNicolas Weiss, Simona Tripon, Maxime Mallet, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 30, 2019
Neurocognitive impairment is associated with erectile dysfunction in cirrhotic patientsSara Philonenko, Pauline Rivière, Maxime Mallet, et al.Clinics and Research in Hepatology and Gastroenterology|March 5, 2021
Prognosis of patients undergoing salvage TIPS is still poor in the preemptive TIPS eraCharlotte Bouzbib, Philippe Cluzel, Philippe Sultanik, et al.Clinics and Research in Hepatology and Gastroenterology|September 4, 2023
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCCSayma Chaibi, Edouard Larrey, Jean Pierre Couty, et al.Alimentary Pharmacology & Therapeutics|July 8, 2024
Other causes of neurocognitive impairment than covert hepatic encephalopathy (CHE) are very frequent, either alone or associated with CHE, in cirrhotic patients with cognitive complaintsPhilippe Sultanik, Lyes Kheloufi, Apolline Leproux, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 28, 2024
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-BevacizumabPhilippe Sultanik, Claudia Campani, Edouard Larrey, et al.Pageof 4